West Pharmaceutical Services Inc banner

Wall St Price Targets

WPS Price Forecast
Based on 18 analysts

+19% Upside
from €368.4 today

West Pharmaceutical Services Inc (WPS)’s 12-month stock price forecast through November 2027 has a consensus target of €437.79, implying 19% upside. The forecast is based on price targets from 18 Wall Street analysts.

WPS Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for WPS yet.

West Pharmaceutical Services Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is WPS's stock price target?
Price Target
437.79 EUR

According to Wall Street analysts, the average 1-year price target for WPS is 437.79 EUR with a low forecast of 304.35 EUR and a high forecast of 469.44 EUR.

What is the Revenue forecast for West Pharmaceutical Services Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.

What is the Gross Profit forecast for West Pharmaceutical Services Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 11%.

What is the Operating Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 5 years is 13%.

What is the Pre-Tax Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 19%.

What is the Net Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 5 years is 12%.

Back to Top